New biologic therapies for psoriatic disease.

Keyphrases

• Biologic Therapy 100%
• New Biologics 100%
• Biological Drugs 100%
• Psoriatic Arthritis 100%
• Immune System 50%
• T Cells 50%
• Phase I Study 50%
• Monoclonal Antibody 50%
• Alefacept 50%
• Etanercept 50%
• FDA-approved Drugs 50%
• Infliximab 50%
• Tumor Necrosis Factor-α 50%
• Recombinant DNA Technology 50%
• Soluble TNF Receptors 50%
• Efalizumab 50%
• Naturally Occurring Molecules 50%
• Remicade 50%
• Individual Life 50%
• Cutaneous Disease 50%
• Enbrel 50%
• Psoriasis 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Product 100%
• Infliximab 100%
• Efalizumab 100%
• Alefacept 100%
• Etanercept 100%
• Diseases 100%
• Tumor Necrosis Factor 50%
• Skin Disease 50%
• Monoclonal Antibody 50%
• Tumor Necrosis Factor Receptor 50%
• Psoriasis 50%
• Recombinant DNA 50%